Streetbeat News

Revenues

FR

Six analysts have recently updated their ratings on First Industrial Realty (NYSE:FR), showing a mix of bullish to bearish sentiments. The average 12-month price target for FR has been raised to $56.00, up 4.34% from the previous $53.67. Analyst actions include both upgrades and downgrades, with price targets ranging from $47.00 to $60.00. First Industrial Realty, a real estate investment trust, has shown strong financial performance with notable revenue growth, high net margin, and efficient asset and equity management.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 12:00 pm

AAPL

Eric Jackson from EMJ Capital suggests buying Apple Inc. (AAPL) stock, citing excessive pessimism among investors despite challenges like declining iPhone sales in China and a DOJ antitrust lawsuit. Apple's stock has fallen 14.27% since its all-time high in December. Jackson believes the upcoming June WWDC event could be a catalyst for the stock. Apple also faces regulatory pressures, including a $1.95 billion fine in a Spotify antitrust case, and has been forced to adopt USB Type-C and RCS due to regulatory decisions.

Portfolio Pulse from Rounak Jain

March 27, 2024 | 11:43 am

NVS

PYXS

Pyxis Oncology has finalized the sale of its royalty rights for Beovu (Brolucizumab-dbll) and another asset to Novartis for $8 million. This transaction provides Pyxis with immediate capital, potentially impacting its financial flexibility and future revenue streams.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:39 am

LOCL

Local Bounti reported preliminary Q1 sales of $8.4M, below the estimated $10.45M but marking a 22% sequential increase due to enhanced productivity at its Georgia facility.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:26 am

GMDA

Gamida Cell announced the start of a restructuring process with the support of Highbridge Capital Management. This strategic move aims to streamline operations and strengthen the company's financial position. The involvement of Highbridge Capital, a well-known investment firm, suggests a significant commitment to turning around Gamida Cell's fortunes.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:09 am

REE

REE Automotive has announced that its orderbook value has now exceeded $50 million, marking a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:57 am

LE

Lands' End has provided its financial outlook for FY24, expecting revenue to range between $1.33B and $1.45B, which is slightly below the $1.46B estimate. The company also projects its adjusted earnings per share (EPS) to be between $0.10 and $0.38, significantly surpassing the estimated $(1.9).

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:56 am

MYND

Mynd.ai reported a decrease in FY23 revenue to $413.6M from $584.6M year-over-year, with an EPS loss of $(0.09) compared to a gain of $0.05 in the previous year. The company's cash balance stands at $91.8M.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:37 am

MRNA

Moderna, Inc. (NASDAQ:MRNA) announced significant advancements in its mRNA vaccine pipeline at its fifth Vaccines Day event, including successful clinical readouts for four vaccines targeting respiratory, latent, and other viruses. The company's diverse portfolio addresses major infectious diseases with 28 vaccines in development. Key updates include progress on vaccines for CMV, EBV, HSV-2, VZV, norovirus, COVID-19, RSV, and influenza. Moderna's CMV vaccine candidate, mRNA-1647, is in a pivotal Phase 3 trial, while its EBV vaccine candidates, mRNA-1189 and mRNA-1195, are advancing towards Phase 3 trials. The company also highlighted its ongoing Phase 3 trials for COVID-19, RSV, and flu vaccines, with mRNA-1345 for RSV showing promising efficacy. Moderna estimates the total addressable market for its infectious disease vaccines at $52 billion, with significant commercial opportunities in the coming years. The company's manufacturing innovation and investment in research and development support the commercialization of its pipeline.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:32 am

AMKBY

The Francis Scott Key Bridge in Baltimore collapsed after a cargo ship operated by Synergy Group and chartered by AP Moller Maersk (OTC:AMKBY) struck it, leading to significant damages and presumed deaths. The bridge is a crucial part of the region's transportation network, affecting over 30,000 vehicles daily. The incident has global trade implications and is expected to result in substantial insurance payouts, potentially comparable to the $1.5 billion from the Costa Concordia crash. President Biden has pledged federal support for the bridge's reconstruction, while legal nuances regarding liability are being discussed.

Portfolio Pulse from Ramakrishnan M

March 27, 2024 | 10:24 am